| Pilot study of a novel application for data visualization in type 1 diabetes JC Wong, AB Neinstein, H Look, B Arbiter, N Chokr, C Ross, S Adi Journal of diabetes science and technology 11 (4), 800-807, 2017 | 26 | 2017 |
| The rising era of immune checkpoint inhibitors in myelodysplastic syndromes N Chokr, R Patel, K Wattamwar, S Chokr Advances in Hematology 2018 (1), 2458679, 2018 | 21 | 2018 |
| Fulminant diabetes in a patient with advanced melanoma on nivolumab N Chokr, H Farooq, E Guadalupe Case Reports in Oncological Medicine 2018 (1), 8981375, 2018 | 21 | 2018 |
| Immunosuppressive therapy in myelodysplastic syndromes: a borrowed therapy in search of the right place RM Shallis, N Chokr, M Stahl, AB Pine, AM Zeidan Expert Review of Hematology 11 (9), 715-726, 2018 | 14 | 2018 |
| Getting personal with myelodysplastic syndromes: is now the right time? N Chokr, AB Pine, JP Bewersdorf, RM Shallis, M Stahl, AM Zeidan Expert review of hematology 12 (4), 215-224, 2019 | 9 | 2019 |
| Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based … AB Pine, N Chokr, M Stahl, DP Steensma, MA Sekeres, MR Litzow, ... Leukemia & lymphoma 61 (6), 1455-1464, 2020 | 6 | 2020 |
| Immune checkpoint inhibitors in triple negative breast cancer: what is the evidence N Chokr, S Chokr J Neoplasm 3 (2), 6, 2018 | 5 | 2018 |
| Screening chest CT prior to allogenic hematopoietic stem cell transplantation M Alhomoud, N Chokr, A Gomez-Arteaga, Z Chen, JG Escalon, ... Transplantation and Cellular Therapy 29 (5), 326. e1-326. e10, 2023 | 3 | 2023 |
| Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with Myelodysplastic Syndromes (MDS): results of a large web … AB Pine, NB Chokr, M Stahl, DP Steensma, MA Sekeres, MR Litzow, ... Blood 132, 1825, 2018 | 2 | 2018 |
| Institutional role conflict in the digital age: The case of diabetes management at school C Puckett, JC Wong, S Talbot, HJ Min, N Chokr SSM-Qualitative Research in Health 3, 100215, 2023 | 1 | 2023 |
| Outcomes of cord blood vs adult stem cell sources in patients with mutated TP53 myeloid malignancies N Chokr, JA Fein, TB Shore, S Mayer, J Hsu, D Guarneri, P Desai, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | 1 | 2023 |
| Measurable residual disease after CAR T-cell therapy N Chokr, A Gomez-Arteaga Seminars in Hematology 60 (1), 34-41, 2023 | 1 | 2023 |
| Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis S Yamshon, C Gribbin, M Alhomoud, N Chokr, Z Chen, M Demetres, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following … M Alhomoud, C Magro, S Seshan, T Zhang, A Gomez-Arteaga, N Chokr, ... Bone Marrow Transplantation 58 (11), 1270-1274, 2023 | | 2023 |
| Institutional role conflict in the digital age: The case of diabetes management at school. S Talbot, H Min, N Chokr, C Puckett, J Wong | | 2023 |
| Transplantation and Cellular Therapy M Alhomoud, N Chokr, A Gomez-Arteaga, Z Chen, JG Escalon, ... | | 2023 |
| Restrictive Transfusions in the Era of Pathogen-Inactivated Platelets: A Single Center Experience RM Shallis, S Gleeson, N Chokr, L Fangyong, W Wei, M Azar, W Schulz, ... Biology of Blood and Marrow Transplantation 25 (3), S365, 2019 | | 2019 |
| Pilot Study of Tidepool's Blip Application for Data Visualization in Type 1 Diabetes (T1D) JC Wong, AB Neinstein, H Look, B Arbiter, N Chokr, C Ross, S Adi Diabetes 65, A224-A224, 2016 | | 2016 |
| SSM-Qualitative Research in Health C Puckett, JC Wong, S Talbot, HJ Min, N Chokr | | |
